Analyst Report: IT

1. EXECUTIVE SUMMARY

Gartner fell 13.19% on Tuesday 3 November 2026, closing at $204.22 on volume of 3,226,000 shares, 3.12x the 50-session average, after it reported third-quarter results before the open. The company beat on adjusted EPS and raised full-year guidance, yet Seeking Alpha attributed the sell-off to cautious guidance, slower sales cycles and macro risks. The most specific negative item in the brief is management's comment on the call that ex-federal contract value growth is not expected to reach the 4% exit rate by the end of 2026 (GuruFocus). The stock had gained 2.83% on the prior session and closed at $235.26 on 2 November, so the print arrived after a strong run. The shares now trade at a forward P/E of 12.4. The next test is the fourth-quarter report, whose date the brief does not confirm.

2. THE CATALYST

Gartner released Q3 2026 results before the open on 3 November, the session in which the shares fell (SEC 8-K exhibit). The figures reported:

Full-year guidance moved up to revenue of at least $6.405bn, EBITDA of at least $1.615bn, adjusted EPS of at least $14.65 and free cash flow of at least $1.235bn (GuruFocus). Financial News said revenue beat the roughly $1.49bn FactSet estimate.

The reaction rested on the details. Management said ex-federal contract value growth would not reach the 4% exit rate by year-end 2026 (GuruFocus), and the company's stated practice is not to guide on contract value (Benzinga transcript). A Barron's headline framed the fourth-quarter forecast as weak despite the raised full-year outlook, and a Finviz headline from Benzinga said contract value reacceleration was slower than the raised guidance implied. Both are headline-level only, since the underlying articles could not be opened.

The session opened at $208.00, which was also its high, and traded as low as $185.00 before closing at $204.22. AskTraders cited an 18% intraday fall, which is not the close.

3. COMPANY PROFILE

Gartner is an information technology services company in the technology sector. It sells research and advisory insights through three segments: Insights (subscriptions), Conferences and Consulting. Its market cap is $12.90bn, and the brief names no direct competitors. The peer group in the facts (Accenture, IBM, Cognizant) consists of IT consulting and services companies.

Recent results from the brief:

• Q3 contract value was $5.3bn. GTS contract value was $4.0bn (+2.1% YoY) and GBS was $1.3bn (+3.7% YoY), per the company release. Ex-federal growth was 2.8% (GuruFocus).
• The company repurchased 0.9m shares for $138m in the quarter and $1.7bn over the last four quarters (SEC 8-K exhibit).
• CEO Gene Hall said contract value growth accelerated again (SEC 8-K exhibit).
• Contract optimization revenue was $150m on a last-twelve-months basis, which management called variable (GuruFocus).
• Guidance was also raised with the Q1 release on 5 May and again with Q2 (SEC 8-K exhibits).
• A securities class action covers investors who bought between 4 February 2025 and 2 February 2026 (Simply Wall St; date not confirmed).

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The earnings and guidance numbers improved. The drop therefore came from expectations. A StockStory preview on 2 November noted the stock was up 22.9% over the prior month, against an IT services group that averaged a 1.3% gain, and the average analyst target of $193.77 sat well below the $230.85 share price quoted there. Inference: a stock priced for a clean reacceleration had little room for slower new business and a contract value outlook that stopped short of the 4% exit rate. Both segments' new business declined year on year, which gives the market a concrete reason to doubt the growth path.

Peers. Accenture fell 2.45%, Cognizant 1.94% and IBM 0.98% over the same period, while the S&P 500 rose 0.36%. The peer weakness is much smaller than Gartner's decline, so the move was mostly company-specific, with perhaps some sector drag (inference).

Comparable episode. After Q4 2025 results on 3 February 2026, the shares fell more than 20% by midday on a revenue miss and a 2026 outlook below projections, and a sustained sell-off to a 52-week low followed (Business Wire via Barchart; FinancialContent). That episode involved weak guidance, whereas this time guidance rose. The 52-week low of $124.25 came on 22 June 2026, and the stock has since recovered to $204.22.

Analyst views. Targets in the brief are undated, so timing is uncertain. Truist (Jasper Bibb) raised its target to $235 from $205 with a Buy rating, citing Symposium meetings. Wells Fargo (Jason Hass) lifted its target to $175 from $150 with Underweight. Morgan Stanley (Toni Kaplan) cut to $173 from $183 with Equal Weight. The consensus average was $186.08 with a range of $150 to $229 (stockanalysis.com, undated), below the closing price of $204.22.

Bull case. Guidance rose for the third report running, buybacks continue, adjusted EPS grew 30.1%, and the forward P/E of 12.4 is low for a company that raised its outlook. Management attributes client re-engagement to AI (Motley Fool, summary only).

Bear case. New business is shrinking in both segments, reported revenue fell 1.3%, the fourth-quarter outlook disappointed, the average analyst target sits below the current price, and the company's record this year shows how sharply the shares react to guidance disappointments.

5. TECHNICAL SNAPSHOT

The close of $204.22 sits above the 50-day average of $197.10 and the 200-day average of $169.17, and 20.5% below the 52-week high of $256.90 set on 17 December 2025. The stock remains 64.4% above its June low of $124.25. The nearest support is the $185.00 intraday low of the session; among the daily closes in the table, the latest close of $204.22 is the lowest shown. The nearest resistance is $219.16, the 28 October close. Volume of 3,226,000 was 3.12x the 50-session average, the heaviest of the period shown and consistent with repositioning by institutions rather than a thin move.

6. RISK FACTORS

• Contract value growth below the 4% exit rate would extend the pressure on the shares.
• Falling new business in GTS and GBS could weigh on later revenue.
• The company does not guide on contract value, so investors must rely on management commentary.
• Contract optimization revenue of $150m is variable (GuruFocus).
• The securities class action remains an overhang.
• Federal spending exposure affects the ex-federal growth comparison.
• Macro risks and slower sales cycles were cited by Seeking Alpha.

Dated catalysts. The facts list 3 November as the next earnings date, which is the report just released. Financial News said the fourth-quarter and full-year 2026 results will show whether the revised guidance holds, but the brief gives no confirmed date; check the investor site.

The brief also flags conflicting data: the facts' EPS estimate of 3.93 and revenue estimate of $1.74bn conflict with MarketBeat's $2.84 consensus and Financial News's $1.49bn. The sources disagree on whether the $45m guidance increase applied to revenue (Benzinga) or EBITDA (gloom.sh), so neither figure is used here.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). The stock must hold the $185.00 session low and the 50-day average at $197.10. Broker notes updating targets after the print would drive direction. A recovery toward $219.16 would need evidence that the new business weakness is temporary.

Medium term (1-3 months). Direction depends on the market's read of contract value trends and the fourth-quarter report. Higher contract value growth would support the raised guidance and the low forward multiple. Another soft quarter of new business would put the stock on the pattern seen after the February sell-off.

Long term. The thesis is unchanged on the evidence in the brief: profitability and cash returns are strong and guidance has risen three times this year. The open question is whether subscription growth can accelerate beyond the current 2.5%, which this quarter did not settle. This is analysis only and does not constitute personal financial advice.